Alzahrani AYA

References (3)

Title : Donepezil-based rational design of N-substituted quinazolinthioacetamide candidates as potential acetylcholine esterase inhibitors for the treatment of Alzheimer's disease: in vitro and in vivo studies - Al-Karmalawy_2025_RSC.Med.Chem__
Author(s) : Al-Karmalawy AA , Mohamed AF , Shalaby HN , Elmaaty AA , El-Shiekh RA , Zeidan MA , Alnajjar R , Alzahrani AYA , Al Mughram MH , Shaldam MA , Tawfik HO
Ref : RSC Med Chem , : , 2025
Abstract :
PubMedSearch : Al-Karmalawy_2025_RSC.Med.Chem__
PubMedID: 40027342

Title : In Silico and ADMET Studies of Spiro-Quinazoline Compounds as Acetylcholine Esterase Inhibitors Against Alzheimer's Disease - Aljuaid_2024_CNS.Neurol.Disord.Drug.Targets__
Author(s) : Aljuaid A , Abdulaziz O , Allahyani M , Almehmadi M , Alzahrani AYA , Verma S , Yusuf M , Asif M
Ref : CNS Neurol Disord Drug Targets , : , 2024
Abstract :
PubMedSearch : Aljuaid_2024_CNS.Neurol.Disord.Drug.Targets__
PubMedID: 39473101

Title : Discovery of chalcone derivatives as potential a-glucosidase and cholinesterase inhibitors: Effect of hyperglycemia in paving a path to dementia - Al-ghulikah_2023_J.Mol.Struct_1276_134658
Author(s) : Al-ghulikah HA , Mughal EU , Elkaeed EB , Naeem N , Nazir Y , Alzahrani AYA , Sadiq A , Shah SWA
Ref : J Mol Struct , 1276 :134658 , 2023
Abstract :
PubMedSearch : Al-ghulikah_2023_J.Mol.Struct_1276_134658
PubMedID: